SKINBIOTHERAPEUTICS PLC (SBTX) — Half Year results for the six months ended 31 December 2024 & Launch

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen. Welcome to the SKINBIOTHERAPEUTICS PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time via the Q and A tab that's just situated on the right hand corner of your screen. Please just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today we'll publish those responses where it's appropriate to do so on the Investor Meet company platform. And before we begin, we would just like to submit the following poll. And if you'd give that your kind attention, I'm sure the company would be most grateful. And I would now like to hand you over to the executive management team from SKINBIOTHERAPEUTICS PLC. Stuart, good morning, sir. Good morning. Thank you, Jake. Good morning. Good morning, all. Thank you for taking the time to join us. We just walked through the disclaimer slides, please, Jake. And the next one. We're gonna be walking through our interim results, which run us through to the end of December of last year and give you a little bit of a forward glance of what's happened post period. So we'll be walking through the operational financial highlights, our strategy for the year through till the end of December and our strategy for the coming year. We'll give an operational review on our platform businesses, the BIOTIX pillars, and also on the acquired businesses, both Dermatronics and Biotech Solutions. We'll then walk through the interim financial review for 2425, and then finish off with some outlook and guidance for the rest of this this year, and then with some concluding c...